Advantages of radioiodine over radioindium labeled monoclonal antibodies for imaging solid tumors
- 31 December 1988
- journal article
- research article
- Published by Elsevier in International Journal of Radiation Applications and Instrumentation. Part B. Nuclear Medicine and Biology
- Vol. 15 (3) , 231-233
- https://doi.org/10.1016/0883-2897(88)90100-6
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Detection of colorectal carcinoma by emission-computerized tomography after injection of 123I-labeled Fab or F(ab')2 fragments from monoclonal anti-carcinoembryonic antigen antibodies.Journal of Clinical Investigation, 1986
- Tumor radioimmunolocation: differential antibody retention by antigenic normal tissue and tumor.The Journal of Immunology, 1984
- Localization of 131I-labeled p97-specific Fab fragments in human melanoma as a basis for radiotherapy.Journal of Clinical Investigation, 1983
- Improved tumour localisation using indium-111 labelled antibodies.BMJ, 1983
- Diagnostic Imaging of Malignant Melanoma With Radiolabeled Antitumor AntibodiesJAMA, 1983
- Localization of I-131-Labeled Goat and Primate Anti-Carcinoembryonic Antigen (CEA) Antibodies in Patients with CancerInvestigative Radiology, 1982
- Tumor Imaging with Radioactive Metal Chelates Conjugated to Monoclonal AntibodiesScience, 1982
- Preparation of Iodine-131 Labelled Human Growth Hormone of High Specific ActivityNature, 1962